Abstract
Addition of methyl lithium to d-erythrono-1,4-lactone followed by acid deprotection was shown, by X-ray crystallography, to give 1-deoxy-d-arabinitol, C5H12O4, rather than 1-deoxy-d-ribitol as the major product. The crystal structure exists as hydrogen-bonded chains of molecules running parallel to the c axis which are further linked together by hydrogen bonds. Each molecule is a donor and an acceptor for four hydrogen bonds.
Related literature
For related literature see: Izumori (2002 ▶, 2006 ▶); Granstrom et al. (2004 ▶); Beadle et al. (1992 ▶); Skytte (2002 ▶); Levin (2002 ▶); Howling & Callagan (2000 ▶); Bertelsen et al. (1999 ▶); Takata et al. (2005 ▶); Menavuvu et al. (2006 ▶); Sui et al. (2005 ▶); Hossain et al. (2006 ▶); Zehner et al. (1994 ▶); Donner et al. (1999 ▶); Yoshihara et al. (2008 ▶); Takai & Heathcock (1985 ▶); Zissis & Richtmyer (1954 ▶).
Experimental
Crystal data
C5H12O4
M r = 136.15
Tetragonal,
a = 12.9873 (5) Å
c = 8.3679 (3) Å
V = 1411.41 (9) Å3
Z = 8
Mo Kα radiation
μ = 0.11 mm−1
T = 150 K
0.25 × 0.25 × 0.25 mm
Data collection
Nonius KappaCCD area-detector diffractometer
Absorption correction: multi-scan (DENZO/SCALEPACK; Otwinowski & Minor, 1997 ▶) T min = 0.93, T max = 0.97
3189 measured reflections
855 independent reflections
750 reflections with I > 2σ(I)
R int = 0.020
Refinement
R[F 2 > 2σ(F 2)] = 0.043
wR(F 2) = 0.123
S = 1.00
855 reflections
82 parameters
1 restraint
H-atom parameters constrained
Δρmax = 0.34 e Å−3
Δρmin = −0.39 e Å−3
Data collection: COLLECT (Nonius, 2001 ▶); cell refinement: DENZO/SCALEPACK (Otwinowski & Minor, 1997 ▶); data reduction: DENZO/SCALEPACK; program(s) used to solve structure: SIR92 (Altomare et al., 1994 ▶); program(s) used to refine structure: CRYSTALS (Betteridge et al., 2003 ▶); molecular graphics: CAMERON (Watkin et al., 1996 ▶); software used to prepare material for publication: CRYSTALS.
Supplementary Material
Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808012555/lh2622sup1.cif
Structure factors: contains datablocks I. DOI: 10.1107/S1600536808012555/lh2622Isup2.hkl
Additional supplementary materials: crystallographic information; 3D view; checkCIF report
Table 1. Hydrogen-bond geometry (Å, °).
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| O8—H8⋯O8i | 0.96 | 1.76 | 2.698 (4) | 164 |
| O6—H6⋯O6ii | 1.00 | 1.98 | 2.712 (4) | 128 |
| O4—H4⋯O1iii | 0.98 | 1.77 | 2.718 (4) | 162 |
| O1—H1⋯O4iv | 1.05 | 2.03 | 2.712 (3) | 120 |
Symmetry codes: (i)
; (ii)
; (iii)
; (iv)
.
supplementary crystallographic information
Comment
The demand for the large scale production of rare sugars by biotechnological (Izumori, 2006; Izumori, 2002; Granstrom et al., 2004) and chemical (Beadle et al., 1992) methods is driven by the demand for alternative foodstuffs (Skytte, 2002) and D-tagatose itself is used as a low calorie sweetener (Levin, 2002; Howling & Callagan, 2000; Bertelsen et al. 1999) Rare monosaccharides have been found to demonstrate interesting pharmaceutical properties, for example, D-psicose (Takata et al., 2005; Menavuvu et al., 2006) and D-allose (Sui et al., 2005; Hossain et al., 2006) have significant chemotherapeutic properties and D-tagatose has been found to be an anti-hyperglycemic agent (Zehner et al., 1994; Donner et al., 1999) and therefore potentially useful in the treatment of diabetes.
The methodology developed by Izumori et al. (2002, 2006) for the interconversion of tetroses, pentoses and hexoses by enzymatic oxidation, inversion at C3 with a single epimerase, and reduction to the aldose has been seen to be generally applicable for the 1-deoxy ketohexoses (Yoshihara et al., 2008). In order to investigate the viability of this process to the corresponding pentoses and thus to evaluate their therapeutic potential 1-deoxy-D-arabinitol was synthesized, in 3 steps, from 2,3-O-isopropylidene-D-erythronolactone 1 (Fig.1). It has previously been seen that the four diastereomeric tetraols are very difficult to distinguish between by NMR spectroscopy (Takai & Heathcock, 1985). X-ray crystallography confirmed that the major product was the arabinitol 4 rather than the ribitol 3 which differs only in the stereochemistry at the C2 position (Fig. 2).
The molecules are linked by three hydrogen bonding systems and the structure consists of alternating spiral chains of O6—H6···O6 or O8—H8···O8 hydrogen-bonded molecules running parallel to the c-axis (Fig. 3) interconnected by O1—H1···O4—H4···O1 hydrogen bonds (Fig.4). Each molecule is a donor and acceptor for 4 hydrogen bonds (Fig. 5).
In summary, the stereochemistry at C2 of the title compound 1-deoxy-D-arabinitol 4 was firmly established by X-ray crystallography, the absolute configuration is determined by the use of D-erythronolactone as the starting material. As well as the potential biological properties of 1-deoxy ketoses, they are likely to provide a new set of building blocks for the synthesis of a wide variety of complex biomolecules.
Experimental
The title compound was recrystallized from hot methanol: m.p. 398–400 K; [α]D21 +0.8 (c, 8 in H2O) {Lit. (Zissis & Richtmyer, 1954) m.p. 129–131°C; [α]D20 +0.7 (c, 10 in H2O; l, 4)}.
Refinement
In the absence of significant anomalous scattering, Friedel pairs were merged and the absolute configuration assigned from the starting material.
The H atoms were all located in a difference map, but those attached to carbon atoms were repositioned geometrically. The H atoms were initially refined with soft restraints on the bond lengths and angles to regularize their geometry (C—H in the range 0.93–0.98, O—H = 0.82 Å) and Uiso(H) (in the range 1.2–1.5 times Ueq of the parent atom), after which the positions were refined with riding constraints.
Figures
Fig. 1.
Synthetic scheme.
Fig. 2.
The title compound with displacement ellipsoids drawn at the 50% probability level. H atoms are shown as spheres of arbitary radius.
Fig. 3.
Packing diagram showing the O6—H6···O6 and O8—H8···O8 hydrogen bonds.
Fig. 4.
Packing diagram showing the O1—H1···O4—H4···O1 hydrogen bonds.
Fig. 5.
Packing diagram for the compound projected along the c-axis. Each molecule is a donor and an acceptor for 4 hydrogen-bonds.
Crystal data
| C5H12O4 | Z = 8 |
| Mr = 136.15 | F000 = 592 |
| Tetragonal, I41 | Dx = 1.281 Mg m−3 |
| Hall symbol: I 4bw | Mo Kα radiation λ = 0.71073 Å |
| a = 12.9873 (5) Å | Cell parameters from 815 reflections |
| b = 12.9873 (5) Å | θ = 5–27º |
| c = 8.3679 (3) Å | µ = 0.11 mm−1 |
| α = 90º | T = 150 K |
| β = 90º | Block, colourless |
| γ = 90º | 0.25 × 0.25 × 0.25 mm |
| V = 1411.41 (9) Å3 |
Data collection
| Nonius KappaCCD area-detector diffractometer | 750 reflections with I > 2σ(I) |
| Monochromator: graphite | Rint = 0.020 |
| T = 150 K | θmax = 27.5º |
| ω scans | θmin = 5.3º |
| Absorption correction: multi-scan(DENZO/SCALEPACK; Otwinowski & Minor, 1997) | h = −16→16 |
| Tmin = 0.93, Tmax = 0.97 | k = −11→11 |
| 3189 measured reflections | l = −10→10 |
| 855 independent reflections |
Refinement
| Refinement on F2 | Primary atom site location: structure-invariant direct methods |
| Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
| R[F2 > 2σ(F2)] = 0.043 | H-atom parameters constrained |
| wR(F2) = 0.123 | w = 1/[σ2(F2) + ( 0.07P)2 + 1.26P], where P = (max(Fo2,0) + 2Fc2)/3 |
| S = 1.00 | (Δ/σ)max = 0.002 |
| 855 reflections | Δρmax = 0.34 e Å−3 |
| 82 parameters | Δρmin = −0.39 e Å−3 |
| 1 restraint | Extinction correction: None |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| O1 | 0.64776 (13) | 0.51955 (15) | 0.6622 (3) | 0.0211 | |
| C2 | 0.75127 (18) | 0.5139 (2) | 0.6068 (4) | 0.0186 | |
| C3 | 0.7537 (2) | 0.4842 (2) | 0.4296 (4) | 0.0187 | |
| O4 | 0.85700 (13) | 0.48073 (16) | 0.3723 (3) | 0.0237 | |
| C5 | 0.6897 (2) | 0.5564 (2) | 0.3268 (4) | 0.0235 | |
| O6 | 0.73116 (15) | 0.65798 (14) | 0.3242 (3) | 0.0250 | |
| C7 | 0.8135 (2) | 0.4417 (2) | 0.7135 (4) | 0.0208 | |
| O8 | 0.76689 (14) | 0.34124 (13) | 0.7126 (3) | 0.0216 | |
| C9 | 0.8162 (3) | 0.4788 (2) | 0.8844 (4) | 0.0371 | |
| H21 | 0.7853 | 0.5822 | 0.6286 | 0.0184* | |
| H31 | 0.7208 | 0.4168 | 0.4126 | 0.0196* | |
| H51 | 0.6985 | 0.5315 | 0.2238 | 0.0277* | |
| H52 | 0.6191 | 0.5542 | 0.3475 | 0.0271* | |
| H71 | 0.8827 | 0.4379 | 0.6604 | 0.0259* | |
| H91 | 0.8413 | 0.4265 | 0.9544 | 0.0541* | |
| H92 | 0.8595 | 0.5396 | 0.8958 | 0.0548* | |
| H93 | 0.7474 | 0.4971 | 0.9202 | 0.0552* | |
| H1 | 0.6194 | 0.4722 | 0.5703 | 0.0308* | |
| H8 | 0.7975 | 0.2944 | 0.6379 | 0.0334* | |
| H6 | 0.7418 | 0.6761 | 0.4388 | 0.0359* | |
| H4 | 0.9070 | 0.5369 | 0.3651 | 0.0365* |
Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| O1 | 0.0197 (10) | 0.0197 (9) | 0.0240 (12) | 0.0010 (7) | 0.0042 (9) | −0.0023 (9) |
| C2 | 0.0139 (13) | 0.0193 (12) | 0.0225 (16) | −0.0037 (9) | 0.0006 (12) | −0.0001 (13) |
| C3 | 0.0176 (14) | 0.0167 (12) | 0.0218 (17) | −0.0006 (9) | −0.0011 (12) | 0.0010 (13) |
| O4 | 0.0169 (9) | 0.0213 (9) | 0.0329 (14) | 0.0015 (7) | 0.0061 (10) | 0.0035 (10) |
| C5 | 0.0223 (14) | 0.0269 (15) | 0.0214 (16) | 0.0014 (11) | 0.0013 (13) | 0.0032 (15) |
| O6 | 0.0308 (11) | 0.0215 (10) | 0.0227 (12) | 0.0025 (8) | 0.0056 (11) | 0.0046 (10) |
| C7 | 0.0201 (13) | 0.0204 (13) | 0.0218 (16) | −0.0035 (10) | −0.0045 (13) | −0.0004 (13) |
| O8 | 0.0254 (10) | 0.0189 (10) | 0.0204 (12) | 0.0010 (7) | 0.0049 (10) | 0.0000 (9) |
| C9 | 0.053 (2) | 0.0332 (16) | 0.0253 (15) | −0.0023 (15) | −0.0149 (15) | −0.0036 (13) |
Geometric parameters (Å, °)
| O1—C2 | 1.424 (3) | C5—H51 | 0.927 |
| O1—H1 | 1.051 | C5—H52 | 0.934 |
| C2—C3 | 1.532 (3) | O6—H6 | 0.997 |
| C2—C7 | 1.527 (4) | C7—O8 | 1.438 (3) |
| C2—H21 | 1.008 | C7—C9 | 1.510 (5) |
| C3—O4 | 1.425 (3) | C7—H71 | 1.004 |
| C3—C5 | 1.520 (4) | O8—H8 | 0.959 |
| C3—H31 | 0.985 | C9—H91 | 0.954 |
| O4—H4 | 0.978 | C9—H92 | 0.974 |
| C5—O6 | 1.425 (3) | C9—H93 | 0.972 |
| C2—O1—H1 | 93.6 | C3—C5—H52 | 114.4 |
| O1—C2—C3 | 110.4 (2) | O6—C5—H52 | 113.8 |
| O1—C2—C7 | 109.9 (3) | H51—C5—H52 | 106.4 |
| C3—C2—C7 | 113.6 (2) | C5—O6—H6 | 104.9 |
| O1—C2—H21 | 108.0 | C2—C7—O8 | 109.4 (2) |
| C3—C2—H21 | 112.9 | C2—C7—C9 | 111.7 (2) |
| C7—C2—H21 | 101.7 | O8—C7—C9 | 107.7 (3) |
| C2—C3—O4 | 110.7 (2) | C2—C7—H71 | 104.2 |
| C2—C3—C5 | 112.4 (2) | O8—C7—H71 | 109.3 |
| O4—C3—C5 | 110.1 (2) | C9—C7—H71 | 114.4 |
| C2—C3—H31 | 110.8 | C7—O8—H8 | 113.9 |
| O4—C3—H31 | 109.4 | C7—C9—H91 | 111.2 |
| C5—C3—H31 | 103.2 | C7—C9—H92 | 111.4 |
| C3—O4—H4 | 128.4 | H91—C9—H92 | 108.7 |
| C3—C5—O6 | 111.9 (2) | C7—C9—H93 | 110.4 |
| C3—C5—H51 | 104.0 | H91—C9—H93 | 107.4 |
| O6—C5—H51 | 105.2 | H92—C9—H93 | 107.6 |
Hydrogen-bond geometry (Å, °)
| D—H···A | D—H | H···A | D···A | D—H···A |
| O8—H8···O8i | 0.96 | 1.76 | 2.698 (4) | 164 |
| O6—H6···O6ii | 1.00 | 1.98 | 2.712 (4) | 128 |
| O4—H4···O1iii | 0.98 | 1.77 | 2.718 (4) | 162 |
| O1—H1···O4iv | 1.05 | 2.03 | 2.712 (3) | 120 |
Symmetry codes: (i) y+1/2, −x+1, z−1/4; (ii) y, −x+3/2, z+1/4; (iii) −y+3/2, x, z−1/4; (iv) −y+1, x−1/2, z+1/4.
Footnotes
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH2622).
References
- Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C., Polidori, G. & Camalli, M. (1994). J. Appl. Cryst.27, 435.
- Beadle, J. R., Saunders, J. P. & Wajda, T. J. (1992). US Patent 5 078 796.
- Bertelsen, H., Jensen, B. B. & Buemann, B. (1999). World Rev. Nutr. Diet.85, 98–109. [DOI] [PubMed]
- Betteridge, P. W., Carruthers, J. R., Cooper, R. I., Prout, K. & Watkin, D. J. (2003). J. Appl. Cryst.36, 1487.
- Donner, T. W., Wilber, J. F. & Ostrowski, D. (1999). Diabetes Obes. Metab.1, 285–291. [DOI] [PubMed]
- Granstrom, T. B., Takata, G., Tokuda, M. & Izumori, K. (2004). J. Biosci. Bioeng.97, 89–94. [DOI] [PubMed]
- Hossain, M. A., Wakabayashi, H., Izuishi, K., Okano, K., Yachida, S., Tokuda, M., Izumori, K. & Maeta, H. (2006). J. Biosci. Bioeng.101, 369–371. [DOI] [PubMed]
- Howling, D. & Callagan, J. L. (2000). PCT Int. App. WO 2000 042 865.
- Izumori, K. (2002). Naturwissenschaften, 89, 120–124. [DOI] [PubMed]
- Izumori, K. (2006). J. Biotechnol.124, 717–722. [DOI] [PubMed]
- Levin, G. V. (2002). J. Med. Food, 5, 23–36. [DOI] [PubMed]
- Menavuvu, B. T., Poonperm, W., Leang, K., Noguchi, N., Okada, H., Morimoto, K., Granstrom, T. B., Takada, G. & Izumori, K. (2006). J. Biosci. Bioeng.101, 340–345. [DOI] [PubMed]
- Nonius (2001). COLLECT Nonius BV, Delft, The Netherlands.
- Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307–326. New York: Academic Press.
- Skytte, U. P. (2002). Cereal Foods World47, 224–224.
- Sui, L., Dong, Y. Y., Watanabe, Y., Yamaguchi, F., Hatano, N., Tsukamoto, I., Izumori, K. & Tokuda, M. (2005). Intl. J. Ocology, 27, 907-912. [PubMed]
- Takai, K. & Heathcock, C. H. (1985). J. Org. Chem.50, 3247–3251.
- Takata, M. K., Yamaguchi, F., Nakanose, Y., Watanabe, Y., Hatano, N., Tsukamoto, I., Nagata, M., Izumori, K. & Tokuda, M. (2005). J. Biosci. Bioeng.100, 511–516. [DOI] [PubMed]
- Watkin, D. J., Prout, C. K. & Pearce, L. J. (1996). CAMERON Chemical Crystallography Laboratory, Oxford, UK.
- Yoshihara, A., Haraguchi, S., Gullapalli, P., Rao, D., Morimoto, K., Takata, G., Jones, N., Jenkinson, S. F., Wormald, M. R., Dwek, R. A., Fleet, G. W. J. & Izumori, K. (2008). Tetrahedron Asymmetry, 19, 1739–745.
- Zehner, L. R., Levin, G. V., Saunders, J. P. & Beadle, J. R. (1994). US Patent 5 356 879.
- Zissis, E. & Richtmyer, N. K. (1954). J. Am. Chem. Soc.76, 5515–5522.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808012555/lh2622sup1.cif
Structure factors: contains datablocks I. DOI: 10.1107/S1600536808012555/lh2622Isup2.hkl
Additional supplementary materials: crystallographic information; 3D view; checkCIF report





